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Abstract
Background: Outpatient integrated headache care was established in 2005 at the Essen Headache Centre in
Germany. This paper reports outcome data for this approach.
Methods: Patients were seen by a neurologist for headache diagnosis and recommendation for drug treatment.
Depending on clinical needs, patients were seen by a psychologist and/or physical therapist. A 5-day headache-
specific multidisciplinary treatment programme (MTP) was provided for patients with frequent or chronic migraine,
tension type headache (TTH) and medication overuse headache (MOH). Subsequent outpatient treatment was
provided by neurologists in private practice.
Results: Follow-up data on headache frequency and burden of disease were prospectively obtained in 841
patients (mean age 41.5 years) after 3, 6 and 12 months. At baseline mean headache frequency was 18.1 (SD = 1.6)
days per month, compared to measurement at 1 year follow-up a mean reduction of 5.8 (SD = 11.9) headache
days per month was observed in 486 patients (57.8%) after one year (TTH patients mean: -8.5 days per month;
migraine mean: -3.2 days per month, patients with migraine and TTH mean: -5.9 days per month). A reduction in
headache days ≥ 50% was observed in 306 patients (36.4%) independent of diagnosis, while headache frequency
remains unchanged in 20.9% and increase in 21.3% of the patient.
Conclusion: Multidisciplinary outpatient headache centres offer an effective way to establish a three-tier treatment
offer for difficult headache patients depending on clinical needs.
Background
Headache disorders, especially migraine and tension-
type headache (TTH), not only result in severe indivi-
dual burden but also have serious socioeconomic impact
[1,2]. High costs for the health care system as well as
reduced work capacity and impairments in social life
indicate the relevance of these headache disorders [3].
Frequent headaches lead patients to repeated hospitali-
zations, consultation of different medical specialists and
expenditure on alternative therapies due to the fact that
their understanding of headache may be based on dys-
functional conceptions and lack of information. Stan-
dard care for headache is provided by general
practitioners in Germany, only a part of the patients are
treated by neurologists. Most of primary care physicians
and neurologists are not specialized in headache care. In
general, treatment of chronic migraine, TTH and medi-
cation overuse headache (MOH) is challenging for gen-
eral practioners and neurologists in private practice. As
a consequence, many patients seek help from different
disciplines (dentists, otorhinolaryngologists, orthopedic
surgeons, ophthalmologists etc.). Incorrect diagnosis and
thus unsuccessful treatment result in high costs.
Obviously an unstructured concept of health care is not
sufficient for patients with frequent or difficult-to-treat
headaches. In fact, the recommended access to beha-
vioural psychologists or physiotherapists is not available
within the standard healthcare system. To overcome
these difficulties in daily practice, integrated headache
care was developed and established by health insurance
companies and the University Hospital in Essen, Ger-
many in 2005. Integrated headache care comprises
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any medium, provided the original work is properly cited.different disciplines (neurologists, behavioural psycholo-
gists, physiotherapists) and close collaboration between
hospital, outpatient headache center and private prac-
tice. This follows the suggestions of a three-tier interdis-
ciplinary system for headache care [4-6]. Integrated
headache care started in 2005 in cooperation with
selected health insurance companies and was expanded
over time [7].
In this report prospectively collected baseline and one-
year follow-up data from patients with difficult to treat
headaches are reported focussing on changes in head-
ache frequency from baseline to follow-up and predic-
tors of outcome and treatment success.
Methods
This is a prospective observational study reporting the
first experiences and the outcome of the headache treat-
ment programme of the West German Headache Centre
established in 2005. Due to the observational and non-
interventional character of the evaluation, no randomi-
zation to different treatment modalities was done. Inclu-
sion criteria were a) age > 18 years b) diagnosis of
migraine, TTH, combination headache and/or MOH
according to ICHD-II [8] and c) adequate knowledge of
the German language. The project was approved by the
local Ethics Committee. Informed consent was obtained
from all patients. All patients were seen at the outpati-
ent headache clinic by experienced board certified neu-
rologists who diagnosed the headache type according to
ICHD-II [8] and collected information about demogra-
phy and frequency and intake of acute and preventive
drugs.
Setting and Concept of the West German Headache
Centre
The West German Headache Centre provides an outpa-
tient and day clinic service for patients with frequent
and/or difficult-to-treat headaches who are referred by
neurologists, general practioners or their insurance com-
pany. The multidisciplinary team of the Headache Cen-
tre consists of neurologists, physical and sports
therapists, behavioural psychologists, headache nurses as
well as consultants from other disciplines if needed [5].
Patients suffering from episodic headache with low
headache frequency were given a treatment recommen-
dation for subsequent therapy by their general prac-
tioner or neurologist in private practice. Patients
suffering from more frequent or chronic headache, high
frequency intake of medicine for the treatment of acute
headache episodes (analgesics, NSAID, ergotamine, trip-
tans), medication overuse headache (MOH) or whose
current medication was insufficient were selcted for
more intensive therapy. In a first step, they consulted a
psychologist and/or a physical therapist. The decisions
about these referrals were taken by the neurologist
based on disease history and clinical findings. Initial ses-
sions with psychologists consist of a one-hour face-to-
face contact. For some patients this resulted in treat-
ment recommendations. Most patients received educa-
tion about stress, specific lifestyle changes and other
self-help options. Referral to the physiotherapists con-
sists mainly in evaluation of the musculo-skelettal sys-
tem and education about aerobic endurance training as
a preventive treatment for headache. Difficult-to-treat
patients are referred to the outpatient multidisciplinary
day clinic treatment programme (MTP). The MTP’s
multidisciplinary team consists of neurologists, physical
and sports therapists as well as psychologists. Patients
are educated in how to handle headache in everyday life
by learning strategies of stress management, muscle
relaxation and sports. The 5-day programme is sched-
uled in different sessions that focus on education about
headache (symptoms, etiology and pathophysiology), on
treatment options and on the correct use of headache
medication. Details of the treatment programme were
published elsewhere [9].
Baseline and outcome data
Baseline data were obtained in a structured face-to-face
interview and recorded in a custom-made data base.
Follow-up was performed by three telephone interviews
(after 3, 6 and 12 months) performed by trained medical
students. Demographic and personal data (age, sex,
weight, martial-status, education level) were obtained as
well as the prior and present use of attack-aborting and
prophylactic medication (data not shown). The ques-
tionnaire comprised data on headache frequency, and
burden of disease measured by MIDAS (Migraine dis-
ability Assesment Score) questionnaire [10]. Data were
analyzed for predictors of treatment success (defined as
≥ 50% headache reduction per month).
Statistical analysis
Binary logistic regression was employed to determine
predictors influencing primary outcome, which was
defined as a reduction of > 50% in headache days per
month, resulting in odds ratios (OR) with 95% confi-
dence intervals (CI). The influence of the following vari-
ables: age (< 40 vs. ≥ 40 years; younger half vs. older
half of the patients), smoking status (smoker vs. non-
smoker), weight (BMI < 25 vs. ≥ 25), education level
(low education vs. high education), headache diagnosis
(migraine vs TTH vs combination of migraine and
TTH) treatment in the MTP, headache frequency at
baseline (0-5 days, 6-10 days, 11-15 days, 16-20 days,
21-25 days, 26-30 days) and family status (single vs.
partnership) were calculated. Chi-square tests were used
for comparison of categorical variables. P-value below
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was used for statistics analysis.
Results
Patient characteristics
841 of 1871 patients visiting the headache centre were
interviewed at 3, 6 and 12 months. The others refused
the interviews, provided insufficient data or were lost
to follow-up. We include those patients in which base-
line demographics (age, gender), data on diagnosis, and
headache days (admission and follow-up) were avail-
able. Mean age was slightly different between included
vs the non-included patients (40.9 vs 39.5 years). The
mayority of patients were female within the non-
included (85.7%) and the presented patients (81.9%).
Therefore a representative subgroup not clinically dif-
ferent from the total population treated in the head-
ache centre is presented.
All patients were seen by a neurologist. In addition,
362 (43.0%) were seen by a psychologist, 94 (11.2%)
consultated a physical therapist, and 274 patients
(32.6%) participated the MTP. Allocation to different
cobinations of consultation and additional MTP was dis-
playd (Figure 1). The demographic and diagnostic char-
acteristics of the 841 patients included are displayed in
table 1. The burden of disease was measured by MIDAS
questionnaire. Seventy-five percent of patients suffered
from migraine, 15.7% were diagnosed with migraine and
TTH and 8.5% were suffering from TTH. The highest
headache frequency at admission was reported for
patients with TTH (25.6 headache days per month,
mean). Patients with migraine and TTH had an average
of 16.7 headache days per month and patients suffering
from migraine had a mean headache frequency of 8.9
days per month. The mean duration of disease was 11.7
years.
Outcome and predictors
An overall reduction of headache days per month was
observed in 486 patients (57.8%) after one year (Figure
2). Mean reduction in headache frequency was 5.8 (SD
= 11.9) days per month compared to baseline headache
frequency. Unchanged frequency was reported in 176
patients (20.9%), while an increase of headache days
after one year was reported by 179 patients (21.3%).
The primary outcome (reduction in headache days ≥
50% after one year) was observed in 306/841 patients
(36.4%). The analysis identified two main factors for
favourable outcome: headache frequency at baseline and
age. No other factors (gender, education, smoking, BMI)
(Table 2) were statistically significant.
There was no significant difference regarding the pri-
mary outcome between the headache groups. However,
regarding the absolute reduction of headache days, TTH
patients improved most (mean: -8.5 days per month)
compared to patients with migraine (mean:-3.2 days per
month) and patients with migraine and TTH (mean:
-5.9 days per month).
The course of headache frequency during the one-year
follow-up was analyzed regarding worsening from episo-
dic (< 15 headache days/month) to chronic (> 15 head-
ache days/month) as well as recovery from chronic to
episodic headache. Five-hundred sixty-three (67%)
patients remained episodic, while 25 patients showed a
progression to chronic migraine. In 177 (21%) patients,
the headache frequency declined from a chronic to an
episodic course. Persistence of chronic headache during
one year was documented in 76 patients (9%).
Predictors for primary outcome
Table 2 summarizes the univariate as well as the multi-
variate predictive factors for favourable outcome (≥ 50%
reduction of headache days/month).
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Figure 1 Allocation to different cobinations of consultation and additional MTP. MTP = Multidisciplinary treatment
Gaul et al. BMC Neurology 2011, 11:124
http://www.biomedcentral.com/1471-2377/11/124
Page 3 of 7Table 1 Demographic and Clinical Characteristiscs
Migraine
(n = 637)
Migraine + TTH
(n = 132)
TTH
(n = 72)
Gender n (%) Male 85 (13.3) 11 (8.3) 23 (31.9)
Female 552 (86.7) 121 (91.7) 49 (68.1)
Age, mean (SD) 40.7 (12.7) 38.6 (13.7) 45.3 (17.8)
Education* n (%) Low education 350 (54.9) 69 (52.3) 29 (40.3)
High education 193 (30.3) 44 (33.3) 10 (13.9)
Missíng 94 (14.8) 19 (14.4.) 33 (45.8)
Employment, n (%) Unemployed 30 (4.7) 5 (3.8) 8 (11.1)
Fulltime 441 (69.2) 90 (68.2) 35 (48.6)
Housemaker 68 (10.7) 13 (9.8) 7 (9.7)
Pensioner 33 (5.2) 10 (7.6) 17 (23.6)
Missing 65 (10.2) 14 (10.6) 5 (6.9)
Marital Status, n (%) Single 81 (12.7) 22 (16.7) 12 (16.7)
Partnership 421 (66.1) 77 (58.3) 44 (61.1)
Others 42 (6.6) 12 (9.1) 7 (9.7)
Missing 93 (14.6) 21 (15.9) 9 (12.5)
Smoking, n (%) Yes 91 (14.3) 16 (12.1) 11 (15.3)
No 448 (70.3) 96 (72.7) 47 (65.3)
Missing 98 (15.4) 20 (15.2) 14 (19.4)
Duration of disease, years mean (SD) 19.9 (12.5) 17.2 (13.5) 11.7 (11.5)
Headache frequency at admission days/month, mean (SD) 8.9 (19.9) 16.7 (31.8) 25.6 (34.0)
MIDAS grade** at I 20.2 (20.6) 26.3 (26.4) n.a.
admission, mean (SD) II 18.2 (17.2) 21.7 (21.0) n.a.
III 20.6 (16.4) 22.0 (18.7) n.a.
IV 36.1 (22.9) 37.9 (24.2) n.a
TTH: Tension Type Headache; n.a.: not applicable. * Education level is divided into two groups: a) Low education: no school qualification+ high school
qualification. b) High education: A-level+ University degree, ** MIDAS: Migraine Disability Assessment Score. MIDAS scores are categorized by disability levels:
little or no disability (grade I: 0-5), mild disability (grade II: 6-10), moderate disability (grade III: 11-20), severe disability (grade IV: 20+); S.D.: standard deviation, n:
number of patients.
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Figure 2 Course of headache days during one year. Reduction of headache days per month during one year, grouped for diagnosis and
different dates of exploration. (Migr = migraine, TTH = tension-type headache)
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overuse headache
Fifty-nine of 841 patients were documented with MOH
in one of the questionnaires from baseline to follow-up
3 .F i f t yp a t i e n t sw e r ed o c u m e n t e dw i t hM O Ho n l ya t
baseline. Fivty-three of 59 patients (91.4%) who were
diagnosed with MOH were in the low-education group.
Six (10%) patients showed persistence of MOH during
one year (from baseline to follow-up 3). At the one-year
follow up, three patients (5%) were identified with a
newly-developed MOH.
Burden of disease
Regarding burden of disease, 64% of the patients pre-
sented with MIDAS IV at admission, decreasing to
42.2% after 12 months. As a consequence, MIDAS I
increased from 11% to 26.3% after 12 months (Figure 3).
Discussion
Integrated headache was established to provide multidis-
ciplinary treatment to improve treatment for difficult-
to-treat headache patients. Prospectively collected obser-
vational data of a large cohort of headache patients
Table 2 Predictive factors for favourable outcome (> 50% reduction of headache days/month) of the treatment
programme
Risk Factors (groups, number of patients) Univariate Odds Ratio
(95% CI) P-value
Multivariate Odds Ratio (95% CI) P-value
Age (< 40 years, 367;
> 40 years; 471)
Referent
1.8
(1.35 - 2.39) < .001
Refererent
1.93
(1.33 - 2.79) < .001
Nicotin (yes, 118; no, 588) 0.71 (0.48 - 1.07) 0.10 0.75 (0.48 - 1.18) 0.21
BMI (> 25, 288; < 25, 543) 0.92 (0.69 - 1.24) 0.58 0.98 (0.67-1.43) 0.90
Education (low education, 510; high education, 246) 0.97 (0.71 - 1.33) 0.85 1.02 (0.70-1.50) 0.90
MTP (no, 557; yes, 273) 0.73 (0.54 - 0.97) 0.05 0.70 (0.47-1.02) 0.06
Headache frequency at baseline (number of patients) 0-5 days (251) 1.0 Referent 1.0 Referent
6-10 days (255) 1.39 (0.94 - 2.04) < .001 1.56 (0.99-2.47) 0.05
11-15 days (145) 1.89 (1.22 - 2.93) .004 2.08 (1.24-3.51) < .001
16-20 days (49) 5.03 (2.64 - 9.61) < .001 7.42 (3.29-16.75) < .001
21-25 days (30) 4.38 (2.00 -9.60) < .001 8.65 (3.14-23.84) < .001
26-30 days (108) 2.92 (1.82 - 4.69) < .001 6.57 (3.20-13.49) < .001
Headache diagnosis (n) Migraine (635) 1.0 Referent 1.0 Referent
Migraine + TTH (131) 1.14 (0.77 - 1.68) 0.51 0.69 (0.41-1.17) 0.17
TTH (72) 1.07 (0.65 - 1.77) 0.79 0.34 (0.16-0.73) 0.005*
Family (single, 175; partnership, 540) 0.69 (0.49 - 0.98) 0.04 0.78 (0.52-1.17) 0.23
Patients with migraine, TTH and migraine and TTH are included. * Only measurements which show significance in the univariate analysis and could be confirmed
in the multivariate analysis were were accepted as outcome predictors
0%
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Follow-up
Figure 3 Burden of disease measured with MIDAS. MIDAS (Grade I-IV) of all patients, comparison between baseline and 1-year follow-up
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improvement of headache frequency in 57.8% of the
patients. Thirty-six percent of patients achieved a ≥ 50%
reduction of headache days per month irrespective of
primary headache subgroup. In contrast no improve-
ment (20.9%) or worsening (21.3%) was reported in
remaining patients. Headaches usually show a fluctuat-
ing headache frequency influenced by different factors
(for example psychiatric comorbidity, stress, live-events)
it is expectable that a part of them did not improve or
w o s e nd u r i n gt i m ec o u r s e .A ss h o w ni nar e c e n ts t u d y
of our group adherence to live style modifications pre-
dict primary outcome [9]. It is not surprising that short
or single interventions in a headache center did not
result in improvement of headaches in all patients. In
absolute terms reduction of headache days in TTH was
more pronounced than in migraine. Multivariate analysis
revealed best outcome for patients older than 40 years
compared to the younger. We could not explain this
finding. Another important variable is the number of
headache days per month at baseline. Patients with
migraine and migraine and TTH who suffered from
nearly daily headache (> 25 headache days per month)
showed the best outcome, whereas patients with the
lowest number of headache days (0-5) at baseline
showed almost no change in headache frequency.
Regarding offerd consulation by neurologist and if
possible once in addition by a physical therapists and/or
a psychologist differentiation on outcome one year later
can not be expected. Data does not suggest that addi-
tional MTP resulted in a better outcome. However, the
study was not designed to compare these strategies.
MTP treatment was indicated by headache frequency
and burden of disease, but it was only available if treat-
ment costs were covered by the health insurance. In
addition treatment in the MTP depends on motivation
of the patient and living distance to the headache center.
Therefore treatment allocation was not only determined
by medical aspects. Independet from this we recom-
mend MTP especially in patients suffering from MOH.
Succesful treatment of MOH resulting in reduction of
the reported hiph relapse rate was shown in recent pub-
lished data due to MTP [9]. This might be explained by
specific education and main emphases on MOH during
the MTP.
Jensen et al. performed a 2-year systematic follow-up
in the Danish Headache Centre in order to characterize
patients and treatment results. They identified predic-
tors for good outcome as female gender, migraine as
primary headache, triptan-overuse and a mean headache
frequency of 10 days/month, whereas tension-type head-
ache and overuse of simple analgesics predicted poor
outcome [11]. These results are in some aspects contra-
d i c t o r yt oo u rf i n d i n g s .W ef o u n dn os i g n i f i c a n t
influence of gender or headache type on primary out-
come (≥ 50% reduction of headache frequency). In a
population-based longitudinal study Bigal et al. assessed
the influence of baseline body mass index on the
response to headache preventive treatment. Patients suf-
fering from episodic, chronic or transformed migraine
who sought care in a headache clinic were included.
Baseline information included headache frequency,
number of days with severe headache and headache-
related disability. The same information was obtained
after three months of preventive treatment. After treat-
ment, headache frequency declined in the entire popula-
tion but no significant differences were found among
BMI groups. Furthermore, BMI did not account for
changes in disability, headache frequency, or in the
number of days with severe headache per month [12].
These results are in line with our data in showing no
significant difference in BMI groups and reduction of
headache days with categorization of BMI into only two
subgroups (< 25 vs. ≥ 25) and a longer follow-up (twelve
months). High BMI was a risk factor for increasing
headache frequency in some studies [13,14] but not
others [15,16]. Moreover, we could not find an associa-
tion between smoking and reduction of headache days.
These findings are supported by a metanalysis of three
studies focusing on the association of lifestyle factors
(BMI, alcohol, smoking and physical activity) and head-
ache prevalence in Germany which also found no asso-
ciation between migraine and obesity or smoking [17].
In order to investigate the association between level of
education and reduction of headache frequency, the
education level was split into a high and low education
group. There was no significant difference between level
of education and reduction of headache frequency (≥
50% reduction). However, 91.4% who were diagnosed
with MOH were in the low-education group, indicating
that a lower level of education may be a risk factor for
overuse of medication. This is supported by observations
from Atasoy et al. who evaluated headache characteris-
tics, socioeconomic and educational variabilities in sub-
groups of MOH and migraine patients. Their data
showed that the frequency of migraine attacks as well as
the duration of MOH and lower income was more fre-
quent in low-educated migraine-patients [18]. Scher et
al. identified level of education as factor of headache
chronification [13], which has been shown for MOH,
too [19]. Furthermore, we did not find an association of
marital status and reduction of headache days. Being
married was associated with better prognosis in another
study [13]. The consequence of these observations is
that no patients should be excluded from integrated
headache care based on baseline variables.
We showed cost effectiveness for integrated headache
care treatment [20]. A formal socioeconomic analysis
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of future research.
Strength of our study is the prospective design, the
large cohort and the long follow-up period (12 months).
It is important to investigate long-term effects of head-
ache therapy beyond the 3 months observation time in
clinical trials. Changes in medical treatment as well as
changes in lifestyle and behaviour need time to show an
impact on headache frequency. One of the major limita-
tions of the study is the significant number of patients
lost to follow-up and the high rate of dropouts, as well
as the fact that we could not present a parallel group
design with a cohort receiving standard care from gen-
eral practitioners. Moreover th i si sap r o s p e c t i v eo b s e r -
vational study and not a controlled trial, which has
impact on completeness of the data therefore missings
were indicated in the tables. There is a clear need for
future studies randomizing patients to different treat-
ment modalities to prove the best care. Moreover, the
study population was biased and taken from a tertiary
headache centre taking care of severely affected and
more chronic headache patients. Thus, study results
may not be easily generalized to the headache
population.
Conclusion
In summary, a large number of headache patients and
their response to treatment within a newly-developed
integrated headache care concept in Germany were stu-
died. Multidisciplinary treatment resulted in a reduction
of headache frequency (≥ 50%) especially in older
patients (> 40 years) and in patients with a high number
of headache days at baseline. Regarding burden of dis-
ease, it has been demonstrated that greatly-affected
patients (MIDAS IV) improved during one year. Inter-
disciplinary care has been successfully established and it
is probably even cost-effective. Integrated care is an effi-
cient way to take care of the individual needs of each
severly affected headache patient.
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